About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 1/2NCT01182805

Radiofrequency-based Speckle Tracking Echocardiography to Evaluate Diastolic Function

The purpose of this study is to evaluate a novel ultrasound system's ability to assess the relaxing properties of the heart compared to current techniques.

Lead sponsor: University of Michigan•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

University of Michigan

Collaborators

Pixel Velocity, Inc. / Epsilon Imaging
National Heart, Lung, and Blood Institute (NHLBI)

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients scheduled to undergo a clinically indicated left heart cardiac catheterization will be recruited for the study.

Exclusion Criteria

•Suspected acute ST elevation myocardial infarction.
•Acute coronary syndrome with active ongoing chest pain
•Known or suspected acute aortic dissection
•Known or suspected cardiac tamponade
•Known history of unoperated constrictive pericarditis
•Known or suspected severe aortic stenosis or severe mitral regurgitation
•Heart rhythm other than sinus rhythm on pre-cath EKG
•Age \< 18 years old
•Unable to provide informed consent

Related studies

Comparative Efficacy and Safety of Acetazolamide Versus Metolazone as an Adjunct to Standard Therapy in Patients With Acute Decompensated Heart Failure

NCT07199088 · Acute Decompensated Heart Failure, Heart Failure, Diastolic, and more

RECRUITINGPhase 1

Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Preserved Ejection Fraction

NCT06061549 · Heart Failure, Diastolic, Heart Failure With Preserved Ejection Fraction

Enrolling By InvitationPhase 2

Chronic Exogenous Ketosis in HFpEF

NCT06937320 · Heart Failure With Preserved Ejection Fraction (HFPEF), Heart Failure With Normal Ejection Fraction, and more

Active Not RecruitingPhase 1

AB-1002 in Patients With Class III Heart Failure

NCT04179643 · Congestive Heart Failure, Heart Failure, and more

COMPLETEDPhase 1/2

External Body Pressure in Heart Failure With Preserved Ejection Fraction

NCT05764564 · Heart Failure, Diastolic

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 16, 2023Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1/PHASE2

Enrollment50

Start dateAug 2010

Last updatedOct 16, 2023

Condition

Heart Failure, Diastolic

Locations shown

University of Michigan Cardiovascular Center

Ann Arbor, Michigan

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 16, 2023Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions